200 related articles for article (PubMed ID: 34624569)
1. The M6A methyltransferase METTL3 regulates proliferation in esophageal squamous cell carcinoma.
Zou J; Zhong X; Zhou X; Xie Q; Zhao Z; Guo X; Duan Y
Biochem Biophys Res Commun; 2021 Nov; 580():48-55. PubMed ID: 34624569
[TBL] [Abstract][Full Text] [Related]
2. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
3. The METTL3-m
Qiu Y; Tian Z; Miao TY; Shen L; Chen J; Li PF; Zhu ZX; Zhu ZF; Wu WJ; Xu X; Shen WG
Gene; 2024 May; 908():148281. PubMed ID: 38360124
[TBL] [Abstract][Full Text] [Related]
4. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N
Wang W; Shao F; Yang X; Wang J; Zhu R; Yang Y; Zhao G; Guo D; Sun Y; Wang J; Xue Q; Gao S; Gao Y; He J; Lu Z
Nat Commun; 2021 Jun; 12(1):3803. PubMed ID: 34155197
[TBL] [Abstract][Full Text] [Related]
5. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3.
Liao L; He Y; Li SJ; Zhang GG; Yu W; Yang J; Huang ZJ; Zheng CC; He QY; Li Y; Li B
Cancer Res; 2022 Jul; 82(13):2444-2457. PubMed ID: 35507004
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
8. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
9. m
Xiao D; Fang TX; Lei Y; Xiao SJ; Xia JW; Lin TY; Li YL; Zhai JX; Li XY; Huang SH; Jia JS; Tian YG; Lin XL; Cai KC; Sun Y
Aging (Albany NY); 2021 Sep; 13(17):21497-21512. PubMed ID: 34491904
[TBL] [Abstract][Full Text] [Related]
10. A methyltransferase-like 14/miR-99a-5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2-mediated epigenetic modulation in esophageal squamous cell carcinoma.
Liu Z; Wu K; Gu S; Wang W; Xie S; Lu T; Li L; Dong C; Wang X; Zhou Y
Clin Transl Med; 2021 Sep; 11(9):e545. PubMed ID: 34586732
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
Liang X; Zhang Z; Wang L; Zhang S; Ren L; Li S; Xu J; Lv S
Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602
[TBL] [Abstract][Full Text] [Related]
12. METTL3-mediated m
Han H; Yang C; Zhang S; Cheng M; Guo S; Zhu Y; Ma J; Liang Y; Wang L; Zheng S; Wang Z; Chen D; Jiang YZ; Lin S
Mol Ther Nucleic Acids; 2021 Dec; 26():333-346. PubMed ID: 34513313
[TBL] [Abstract][Full Text] [Related]
13. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
14. METTL3/m
Ge F; Li Z; Hu J; Pu Y; Zhao F; Kong L
Front Pharmacol; 2022; 13():1002565. PubMed ID: 36386128
[TBL] [Abstract][Full Text] [Related]
15. CDK11
Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma.
Guo S; Chen F; Li L; Dou S; Li Q; Huang Y; Li Z; Liu W; Zhang G
J Adv Res; 2023 Aug; ():. PubMed ID: 37619934
[TBL] [Abstract][Full Text] [Related]
17. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
18. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
[TBL] [Abstract][Full Text] [Related]
19. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
20. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]